Efficiency and Safety of Metformine and Pioglitazone in Patients with Coronary Heart Disease and Diabetes Mellitus Type 2

Abstract

A combination of metformin (MF) (2 g daily) and pioglitazone (PG) (30 mg daily) in 57 patients with coronary heart disease (CHD) and diabetes mellitus type 2 (DM 2) reduces the indicators of low grade chronic inflammation (CI): tumor necrosis factor alpha in blood — by 5 times in 6 months of treatment, interleukin-6 — by a 4 times compared to baseline. This combination is safe, has a positive clinical effect on CHD and more effectively normalizes glycated hemoglobin level in patients compared with a combination of MF and sulfonylurea. Since CI is a trigger for the development of atherosclerosis, CHD, arterial hypertension and DM 2, a combination of MF and PG should be considered as an effective and safe agent for the prevention and treatment of these diseases that is confirmed by analysis of modern scientific literature.

Authors and Affiliations

Z. A. Shaienko, M. S. Rasin

Keywords

Related Articles

Psycho-endocrine disorders in adolescents with Graves’ disease

Background. Thyroid dysfunction and mental disorders are common among the general population. In population studies, that thyrotoxicosis has been established to be accompanied by depression and anxiety. The purpose was t...

Adiponectin and Diabetes Mellitus Type 2 (Pathogenic Aspects as the Ground for Antidiabetic Pharmacotherapy Optimization)

The review deals with the role of adipose tissue dysfunction, primarily hypoadiponectinemia, in the development of diabetes mellitus type 2 and its cardiovascular complications. There are accentuated the benefits of oral...

Study of Features of Pregnancy in Women with Onset of Diabetes Type 1 in Prepubertal Period

We studied course of pregnancy in 22 patients with onset of diabetes type 1 in the prepubertal period. It is found that the need for insulin, depending on the duration of pregnancy, varied: decreased in the first trimest...

Typical mistakes in the diagnosis and treatment of diabetes mellitus

The lecture describes in detail the typical mistakes and difficulties of therapy with methodologies of their correction that are made both from the side of physicians and diabetes mellitus patients. The recommendations a...

Adaptive Capacity and Features of Energy Metabolism in Patients with Diabetes Mellitus Type 2

The study of the processes of adaptation and characteristics of energy metabolism in patients with diabetes mellitus (DM) type 2 can serve as a basis for determining their role in the pathogenesis of this disease and con...

Download PDF file
  • EP ID EP222659
  • DOI -
  • Views 76
  • Downloads 0

How To Cite

Z. A. Shaienko, M. S. Rasin (2015). Efficiency and Safety of Metformine and Pioglitazone in Patients with Coronary Heart Disease and Diabetes Mellitus Type 2. Міжнародний ендокринологічний журнал, 2(66), 66-70. https://europub.co.uk/articles/-A-222659